A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach–Nishimura skeletal dysplasia due to pathogenic variants in ALG9Emma Tham, Giedré Grigelioniené, Erik A. Eklund et al.|European Journal of Human Genetics|2015Cited by 39
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocolRachael Sagar, Cecilia Götherström, Anna L. David et al.|BMJ Open|2024Cited by 20